TSE:HSM

Helius Medical Technologies (HSM) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
C$18.35
C$18.35
52-Week Range
N/A
Volume
930 shs
Average Volume
3,578 shs
Market Capitalization
C$42.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Helius Medical Technologies

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

HSM Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Recap: Helius Medical Tech Q4 Earnings
Helius Medical Technologies Inc Class A HSDT
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Helius Medical Technologies
Emerging Markets Report: The Air We Share
Globenewswire | Financial Post
See More Headlines
Receive HSM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$477,000.00
Book Value
C$3.61 per share

Miscellaneous

Free Float
N/A
Market Cap
C$42.54 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Dane Carl Andreeff (Age 55)
    Pres, CEO & Director
    Comp: $2.5k
  • Mr. Jeffrey S. Mathiesen CPA (Age 60)
    CPA, CFO & Treasurer
    Comp: $5k
  • Ms. Joyce N. LaViscount (Age 59)
    COO & Sec.
    Comp: $388.3k
  • Dr. Jonathan Mark Sackier (Age 63)
    Consultant
    Comp: $201.65k
  • Mr. Frederick Fantazzia
    VP of Sales & Marketing- North America
  • Dr. Brian W. Bapty Ph.D. (Age 52)
    VP of Strategy and Bus. Devel.
  • Mr. Mark Leno
    VP & GM of Canadian Operations

HSM Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Helius Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helius Medical Technologies investors own include VanEck Junior Gold Miners ETF (GDXJ), Sleep Country Canada (ZZZ), Acadian Timber (ADN), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ), ATCO (ACO.X), Accord Financial (ACD), Aurora Cannabis (ACB) and Air Canada (AC).

How do I buy shares of Helius Medical Technologies?

Shares of HSM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:HSM) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners